Barclays’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3K | Sell |
|
|||||
|
2025
Q1 | $41K | Sell |
|
|||||
|
2024
Q4 | $262K | Sell |
|
|||||
|
2024
Q3 | $934K | Buy |
|
|||||
|
2024
Q2 | $750K | Sell |
|
|||||
|
2024
Q1 | $1.83M | Buy |
|
|||||
|
2023
Q4 | $352K | Buy |
|
|||||
|
2023
Q3 | $43K | Sell |
|
|||||
|
2023
Q2 | $614K | Sell |
|
|||||
|
2023
Q1 | $815K | Sell |
|
|||||
|
2022
Q4 | $1.36M | Buy |
|
|||||
|
2022
Q3 | $918K | Buy |
|
|||||
|
2022
Q2 | $157K | Sell |
|
|||||
|
2022
Q1 | $166K | Sell |
|
|||||
|
2021
Q4 | $561K | Buy |
|
|||||
|
2021
Q3 | $312K | Sell |
|
|||||
|
2021
Q2 | $778K | Sell |
|
|||||
|
2021
Q1 | $2.03M | Buy |
|
|||||
|
2020
Q4 | $549K | Sell |
|
|||||
|
2020
Q3 | $538K | Buy |
|
|||||
|
2020
Q2 | $659K | Buy |
|
|||||
|
2020
Q1 | $151K | Sell |
|
|||||
|
2019
Q4 | $248K | Buy |
|
|||||
|
2019
Q3 | $46K | Buy |
|
|||||
|
2019
Q2 | $115K | Buy |
|
|||||
|
2019
Q1 | $71K | Buy |
|
|||||
|
2018
Q4 | $18K | Sell |
|
|||||
|
2018
Q3 | $92K | Buy |
|
|||||
|
2018
Q2 | $46K | Sell |
|
|||||
|
2018
Q1 | $68K | Buy |
|
|||||
|
2017
Q4 | $13K | Sell |
|
|||||
|
2017
Q3 | $66K | Buy |
|